UV Adhesive Regulatory Compliance: EU Ink Regulation, FDA 21 CFR 175.105 and ISO 10993 Biocompat

Overview #

The compliance gap that creates the most risk when sourcing UV adhesives from China is not material performance — it is documentation. Most Chinese UV adhesive suppliers can produce a product that passes a single-point test. What they cannot consistently produce is a traceable compliance package that satisfies EU Ink Regulation, FDA 21 CFR 175.105, or ISO 10993 simultaneously — because those three frameworks ask fundamentally different questions, and most suppliers have only ever been asked one of them. When a procurement team requests “food contact compliance” without specifying which regulatory framework governs their end application, they will receive whatever certificate the supplier has on file. That certificate may be irrelevant to their market.

Regulatory Scope and Framework Mapping #

The first decision in UV adhesive compliance sourcing is not which supplier to use — it is which regulatory framework actually governs your application. This is where most specification errors originate.

The three frameworks most commonly required by global buyers of UV-cured structural and laminating adhesives are:

• EU Ink Regulation (pending framework) and its predecessor Framework Regulation (EC) No 1935/2004 — governing food contact materials in the EU market
• FDA 21 CFR 175.105 — the US federal standard for adhesives used in food contact applications
• ISO 10993 — the biocompatibility evaluation series for adhesives used in medical device manufacturing

These are not interchangeable. A UV adhesive with FDA 21 CFR 175.105 compliance is not automatically compliant with EU Framework Regulation 1935/2004, and neither of those certifications addresses the cytotoxicity, sensitization, or genotoxicity requirements under ISO 10993-5 and ISO 10993-10 that medical device buyers require.

The industry observation that matters here: most English-language compliance documentation available from Chinese UV adhesive suppliers is written for the EU food contact market, because that is the largest export compliance request they receive. Buyers sourcing for US food packaging or medical device assembly frequently receive EU-framed documentation and assume it covers their regulatory requirement. It does not.

For UV adhesives used in structural bonding and lamination applications, the applicable framework depends entirely on the downstream product category — food packaging, medical device, electronics assembly, or general industrial. Specifying the wrong framework at the RFQ stage is the single most common compliance error we see in incoming qualification packages.

FDA 21 CFR 175.105: What the Standard Actually Requires #

FDA 21 CFR 175.105 governs adhesives used in the manufacture of food contact articles. The regulation does not certify adhesives directly — it establishes a positive list of permitted substances and requires that the cured adhesive, when used as intended, does not transfer components to food at levels that would be unsafe or that would constitute adulteration.

The practical implication for sourcing: a supplier claiming “FDA 21 CFR 175.105 compliance” must be able to demonstrate that every raw material in the UV adhesive formulation — photoinitiator, monomer, oligomer, additive — appears on the permitted substance list under 21 CFR 175.105(c) or is otherwise authorized under applicable FDA regulations. This is a formulation-level review, not a finished-product test. We have seen suppliers present a single-page “FDA compliance letter” that references the regulation number without any substance-by-substance breakdown. That document is not compliance evidence — it is a marketing statement.

The photoinitiator selection is the highest-risk element in UV adhesive FDA compliance. Several photoinitiators commonly used in Chinese UV adhesive formulations — including certain benzophenone derivatives and thioxanthone compounds — have migration concerns under FDA scrutiny and are subject to specific use restrictions. Buyers should request the full formulation ingredient list mapped against 21 CFR 175.105(c) permitted substances, not just a compliance declaration letter.

For food packaging applications, the relevant extraction test is typically conducted at 49°C for 24 hours in food simulants representing aqueous, acidic, alcoholic, and fatty food types. The overall migration limit under FDA guidance aligns with the EU threshold of 10 mg/dm² for most applications, but substance-specific limits under 21 CFR can be significantly lower — some photoinitiator-derived substances are restricted to 0.05 mg/kg food contact.

Most procurement teams over-specify tensile strength and UV cure speed when sourcing UV adhesives for food packaging, and under-specify the photoinitiator migration profile — which is the parameter that determines whether the adhesive is actually usable in their application.

ISO 10993 Biocompatibility: The Medical Device Buyer’s Framework #

For UV adhesives used in medical device assembly — bonding catheter components, encapsulating sensors, sealing diagnostic cartridges — the governing framework is the ISO 10993 series, specifically:

• ISO 10993-1: Biological evaluation framework and risk-based approach
• ISO 10993-5: Tests for in vitro cytotoxicity (cell viability threshold: ≥70% relative cell viability required for pass)
• ISO 10993-10: Tests for skin sensitization and irritation
• ISO 10993-12: Sample preparation and reference materials

The ISO 10993-5 cytotoxicity test is the minimum entry requirement for any UV adhesive entering a medical device supply chain. The test is conducted on cured adhesive extracts using L929 mouse fibroblast cells, with a pass threshold of ≥70% relative cell viability after 24-hour exposure. This is a binary pass/fail result, and the test must be conducted on the fully cured adhesive — not the uncured liquid — because UV cure completeness directly affects residual monomer levels, which are the primary cytotoxicity driver.

This is where sourcing from China introduces a specific risk. In our supplier qualification program, we have encountered UV adhesive suppliers who submit ISO 10993-5 test reports conducted on samples cured under laboratory conditions — 1000 mW/cm² for 30 seconds — that do not reflect the cure conditions achievable in the buyer’s production process. When the same adhesive is cured at 400 mW/cm² for 10 seconds on a production line, residual monomer content increases significantly, and the cytotoxicity result can shift from pass to fail. The test report is technically accurate; the compliance claim is not.

Buyers sourcing UV adhesives for medical device applications should require ISO 10993-5 test reports that specify the exact cure conditions used during sample preparation, and should verify that those conditions are achievable in their own process. If the supplier cannot provide this detail, the test report is not usable for regulatory submission.

For adhesive and sealing applications in regulated industries, the documentation package for ISO 10993 compliance should include: the test report with sample preparation conditions, the testing laboratory’s ISO 17025 accreditation certificate, and a statement of the adhesive lot number tested. Lot-to-lot consistency is not guaranteed by a single test report — and this is a point that most Chinese suppliers do not proactively address.

EU Framework Regulation 1935/2004 and REACH Compliance #

The EU food contact framework for adhesives operates under Framework Regulation (EC) No 1935/2004 combined with the general principles of good manufacturing practice under Regulation (EC) No 2023/2006. Unlike the US FDA approach, the EU framework does not maintain a single positive list for adhesives — the harmonized EU-specific measure for adhesives is still under development, which means compliance currently relies on national regulations (German BfR recommendations, French DGCCRF lists, Dutch Commodities Act) plus the general safety requirement.

The practical consequence: “EU food contact compliant” is not a single, verifiable certification for UV adhesives. It is a composite claim that must be supported by a Declaration of Compliance (DoC) referencing the specific national regulations and substance restrictions applicable to the buyer’s market. A DoC written for the German market referencing BfR Recommendation XXXVI may not satisfy French or Dutch regulatory requirements for the same adhesive.

REACH Regulation (EC) 1907/2006 applies independently of food contact status. Any UV adhesive formulation containing Substances of Very High Concern (SVHCs) above 0.1% w/w in the article must be disclosed. The SVHC candidate list is updated twice yearly by ECHA, and several photoinitiators and acrylate monomers used in UV adhesive formulations have been added in recent update cycles. Buyers should request an up-to-date SVHC screening report — not a declaration dated more than 12 months prior — because a formulation that was REACH-compliant 18 months ago may not be compliant today if new SVHCs have been listed.

Three out of five Chinese UV adhesive suppliers we evaluated for EU food contact applications could not produce a current SVHC screening report. Two of the five provided declarations referencing superseded ECHA candidate list versions.

Practical Guidance for Buyers #

When sourcing UV adhesives from China for regulated applications, the first document to request is not the TDS — it is the full ingredient disclosure mapped against the applicable regulatory framework. Most suppliers will send a TDS and a one-page compliance letter by default. Neither document tells you whether the photoinitiator package is permitted under your specific regulatory requirement.

The sourcing mistake with the most serious consequence is accepting a compliance declaration without verifying the test conditions. An ISO 10993-5 cytotoxicity pass report means nothing if the cure conditions used for sample preparation are not achievable in your production process. We have seen qualification programs advance to volume order stage before this discrepancy was identified — at which point the buyer faced either a process change or a re-test cycle, both of which carry schedule and cost impact.

Before committing to a volume order of UV adhesives for any regulated application, require the following documentation package: (1) full formulation ingredient list with CAS numbers mapped against the applicable positive list or permitted substance register; (2) third-party test report from an ISO 17025-accredited laboratory specifying exact sample preparation and cure conditions; (3) current SVHC screening report dated within 12 months; (4) Declaration of Compliance referencing the specific regulation and national framework applicable to your market; (5) three consecutive batch COAs demonstrating lot-to-lot consistency in viscosity (±10% of nominal), cure speed, and hardness. If a supplier cannot provide all five, do not proceed to volume qualification.

Frequently Asked Questions #

Q1: What is the most critical test parameter to verify in a UV adhesive compliance package for medical device applications?

A: Cure conditions during sample preparation. An ISO 10993-5 cytotoxicity pass result is only valid if the cure conditions used — irradiance in mW/cm² and exposure time — match what is achievable in your production process. Residual monomer content, which drives cytotoxicity, increases significantly at lower cure doses.

Q2: Is FDA 21 CFR 175.105 compliance equivalent to EU food contact compliance for UV adhesives?

A: No. FDA 21 CFR 175.105 operates on a positive list of permitted substances with substance-specific migration limits, while EU compliance under Framework Regulation (EC) No 1935/2004 relies on national regulations and a Declaration of Compliance referencing the specific applicable framework. A supplier holding one does not automatically hold the other, and the documentation requirements are different for each market.

Q3: What is the most common compliance failure we see when qualifying Chinese UV adhesive suppliers?

A: Outdated SVHC screening reports. The REACH candidate list is updated twice yearly, and several acrylate monomers and photoinitiators used in UV adhesive formulations have been added in recent cycles. A declaration dated more than 12 months prior is not reliable. This is where most sourcing decisions go wrong — the threshold is 0.1% w/w, and the list changes.

Q4: What certification documentation should I require before placing a volume order of UV adhesives for food packaging?

A: Request a full ingredient disclosure with CAS numbers mapped against FDA 21 CFR 175.105(c) permitted substances (for US market) or the applicable national positive list (for EU market), plus a third-party migration test report from an ISO 17025-accredited laboratory specifying food simulant type, temperature (49°C), and contact duration (24 hours). A compliance letter without these specifics is not sufficient for regulatory submission.

Q5: Can a single UV adhesive formulation be compliant with FDA 21 CFR 175.105, EU food contact regulations, and ISO 10993 simultaneously?

A: Technically possible, but rare in practice. The photoinitiator and monomer selection constraints imposed by each framework are different enough that most formulations are optimized for one regulatory target. Buyers requiring multi-framework compliance should state all applicable frameworks at the RFQ stage — not after sample approval.

Published by sinoraw.com Technical Team | Request a sourcing consultation